HOUSE_OVERSIGHT_024740.jpg
2.5 MB
Extraction Summary
0
People
4
Organizations
7
Locations
3
Events
0
Relationships
3
Quotes
Document Information
Type:
Investment report / financial analysis
File Size:
2.5 MB
Summary
This document is page 104 of a December 2017 Cannabis Investment Report authored by Ackrell Capital, LLC. It analyzes market trends, including the medical efficacy of cannabis, the increase in recreational legalization (citing Uruguay, Canada, and US states like Colorado and California), product innovation, and pricing dynamics between legal and illegal markets. The document bears a 'HOUSE_OVERSIGHT_024740' stamp, indicating it was part of a document production for a Congressional investigation, though the text itself contains no direct references to Jeffrey Epstein or specific individuals.
Organizations (4)
| Name | Type | Context |
|---|---|---|
| Ackrell Capital, LLC | ||
| FINRA | ||
| SIPC | ||
| House Oversight Committee |
Timeline (3 events)
Locations (7)
| Location | Context |
|---|---|
Key Quotes (3)
"We believe that federal legalization will trigger rapid growth in the U.S. market, propelled by interstate commerce, access to the federal banking system and acceleration of the cannabis-derived pharmaceuticals market."Source
HOUSE_OVERSIGHT_024740.jpg
Quote #1
"In aggregate, across all U.S. state laws, cannabis is legally recognized as a form of therapy or medicine for more than 50 medical conditions."Source
HOUSE_OVERSIGHT_024740.jpg
Quote #2
"We expect 2018 will be a watershed year for the recreational market, with the implementation of California’s new recreational law and the expected approval and implementation of Canada’s recreational law."Source
HOUSE_OVERSIGHT_024740.jpg
Quote #3
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein document